Numinus Wellness Increases Financing To $15.0 Million

Numinus Wellness (TSXV: NUMI) has increased the size of the bought deal financing that it announced this morning, raising the total gross proceeds intended to be raised from $10.0 million to $15.0 million. The psychedelics firm as a result expects to now sell a total of 22.1 million units of the company.

As we addressed this morning, units will be sold at a price of $0.68 each, containing one common share and one half of a common share purchase warrant. Purchase warrants are valid for a period of 24 months from the date of issuance, and are exercisable at $0.90 per share.

An over allotment option has been granted on the upsize of the offering, enabling the underwriters to increase the offering by up to $2.3 million in gross proceeds. If exercised in full, an additional 3.3 million units of the company will be sold. The over allotment option is good for a period of 30 days following the closing date.

The offering is expected to close December 29, with the use of proceedings including a laundry list of items focused on expanding the firms research as well upgrading and expanding its facilities along with general working capital purposes.

Numinus Wellness last traded at $0.77 on the TSX Venture.


Information for this briefing was found via Sedar and Numinus Wellness. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Barrick Mining’s “Company Defining [Gold] Discovery”

America Uses More Copper Than It Makes | Simon Quick – Canadian Copper

Gold Bulls Run Faster Than New Mines?! | Thomas Mumford – Scottie Resources

Recommended

ESGold Secures $9 Million In Non-Dilutive Funding From Ocean Partners

Altamira Gold Encounters Porphyritic Intrusive Rocks In Initial Scout Drilling At Regional Targets

Related News

Numinus Wellness To Collaborate With MAPS On Proposed MDMA-Assisted Psychotherapy Trials

Numinus Wellness (TSXV: NUMI) this morning announced that it has entered into an arrangement with...

Wednesday, December 2, 2020, 08:28:51 AM

Numinus Wellness Halts Stock For Trading Day To Announce $17 Million Financing Closing

After halting trading in its equity all day, Numinus Wellness (TSXV: NUMI) this evening finally...

Tuesday, December 29, 2020, 04:49:21 PM

Numinus Wellness To Conduct $30 Million Bought Deal

Numinus Wellness (TSXV: NUMI) this morning announced that it will be raising funds again. The...

Monday, March 15, 2021, 09:27:11 AM

Numinus Releases 2020 Operational Objectives

Numinus Wellness (TSXV: NUMI) released its near term 2020 objectives this morning related to its...

Thursday, May 28, 2020, 08:33:29 AM

Numinus Wellness To Acquire Novamind In All Stock Transaction At $0.44 Per Share

Consolidation within the psychedelics space is getting underway, with the announcement this morning that Numinus...

Tuesday, April 12, 2022, 07:56:51 AM